跳至主要内容
临床试验/NCT01973842
NCT01973842Unknown2 期

Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients Undergoing Ovarian Stimulation for IVF With GnRH Antagonists and Recombinant FSH.

Aristotle University Of Thessaloniki2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
90
试验地点
2
主要终点
Percentage of mature oocytes retrieved

研究概览

简要总结

The present study aims to investigate whether the dosage of the GnRH agonist used for triggering final oocyte maturation affects the maturity of the oocytes retrieved in high risk for OHSS patients undergoing ovarian stimulation for IVF using GnRH antagonists and recombinant FSH.

详细描述

Three different doses of GnRH agonist (0.1mg, 0.2mg or 0.4 mg) will be used randomly to trigger final oocyte maturation. The primary outcome measure will be the percentage of mature oocytes retrieved.

Secondary outcomes will include: number of oocytes retrieved, oocyte recovery rate (number of oocytes retrieved/ number of follicles >11mm in diameter on the day of triggering), fertilization rates and OHSS occurrence.

Serum LH, FSH, E2, PRG levels will be assessed at 8-36 hours following agonist administration and on days 3-4-7-10 after triggering final oocyte maturation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients undergoing ovarian stimulation for IVF using GnRH antagonist protocol
  • Age < 40 years
  • Anticipated high ovarian response

排除标准

  • Endometriosis > than grade II
  • One ovary

研究组 & 干预措施

0.4 mg triptorelin

Active Comparator

0.4 mg triptorelin compared with 0.1 mg triptorelin and 0.2 mg triptorelin

干预措施: 0.4 mg triptorelin (Drug)

0.2 mg triptorelin

Active Comparator

0.2 mg triptorelin compared with 0.1 mg triptorelin and 0.4 mg triptorelin

干预措施: 0.2 mg triptorelin (Drug)

0.1 mg triptorelin

Active Comparator

0.1 mg triptorelin compared with 0.2 mg triptorelin and 0.4 mg triptorelin

干预措施: 0.1 mg triptorelin (Drug)

结局指标

主要结局

Percentage of mature oocytes retrieved

时间窗: 36 hours post GnRH agonst administration

Percentage of mature oocytes retrieved following oocyte retrieval

次要结局

  • oocyte recovery rate(36 hours post GnRH agonist administration)
  • Duration of luteal phase(16 days)
  • total number of oocytes retrieved(36 hours post GnRH agonist administration)
  • Fertilization rate(Day 1 post oocyte retrieval)
  • Serum LH, FSH, E2, PRG levels(8-36 hours post triggering and on days 3-4-7-10 after GnRH agonist administration)
  • OHSS occurrence(16 days post triggering)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

E.M. Kolibianakis

Ass Professor in Obstetrics - Gynecology and Assisted Reproduction

Aristotle University Of Thessaloniki

研究点 (2)

Loading locations...

相似试验